Mike Clayman, MD Chief Executive Officer
Mike brings over 20 years of experience in pharmaceutical development. Most recently, he was Vice President, Lilly Research Laboratories and General Manager of Chorus, Lilly's development accelerator.
During a long career at Lilly, Mike led major components of Lilly Research Laboratories including Global Regulatory Affairs (where he managed seven global submissions), Cardiovascular Discovery Research and Clinical Investigation, Product Development and Technology at Advanced Cardiovascular Systems (a subsidiary of Eli Lilly), the Internal Medicine Division, and the Lilly Clinic (Eli Lilly's dedicated Phase I unit). He also served as Chair of Lilly's Bioethics Committee.
Mike received a BA, cum laude, from Yale University, and MD from the University of California-San Diego School of Medicine. Following internship and residency in internal medicine at the UC San Francisco Moffitt Hospitals, he completed clinical and research fellowships in nephrology at the University of Pennsylvania. He was appointed Assistant Professor in the School of Medicine at the University of Pennsylvania and is a recipient of the Physician Scientist Award from the National Institutes of Health.